$0.8861
At close: Apr 11, 4:00 PM EDT
$0.8861
0.000.00%
Pre-Market: Apr 11, 4:00 PM EDT
Comments
Loading...
Inozyme Pharma (INZY) Forecast
NewsEarningsInozyme Pharma (INZY) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Inozyme Pharma Stock Price, Quotes and Forecasts | NASDAQ:INZY | Benzinga
Explore Inozyme Pharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for INZY.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Inozyme Pharma (INZY) stock?
You can purchase shares of Inozyme Pharma (NASDAQ:INZY) through any online brokerage.
Who are Inozyme Pharma (INZY) competitors?
Other companies in Inozyme Pharma’s space includes: Renovaro (NASDAQ:RENB), Serina Therapeutics (AMEX:SER), Cabaletta Bio (NASDAQ:CABA), bluebird bio (NASDAQ:BLUE) and Inovio Pharmaceuticals (NASDAQ:INO).
What is the forecast, or price target, for Inozyme Pharma (INZY) stock?
Inozyme Pharma has a consensus price target of $15.91.
What is the current price for Inozyme Pharma (INZY)?
The stock price for Inozyme Pharma (NASDAQ: INZY) is $0.8861 last updated April 11, 2025 at 4:00 PM EDT.
Does Inozyme Pharma (INZY) pay a dividend?
There are no upcoming dividends for Inozyme Pharma.
When is Inozyme Pharma (NASDAQ:INZY) reporting earnings?
Inozyme Pharma’s Q1 earnings are confirmed for Tuesday, May 6, 2025.
Is Inozyme Pharma (INZY) going to split?
There is no upcoming split for Inozyme Pharma.
What sector and industry does Inozyme Pharma (INZY) operate in?
Inozyme Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.